Johnson Matthey PLC (LON:JMAT) Receives GBX 1,993.33 Consensus PT from Analysts

Shares of Johnson Matthey PLC (LON:JMATGet Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is GBX 1,993.33 ($26.33).

Several equities analysts recently weighed in on JMAT shares. Berenberg Bank restated a “hold” rating and issued a GBX 1,800 ($23.78) price objective on shares of Johnson Matthey in a report on Tuesday, June 11th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 2,400 ($31.70) target price on shares of Johnson Matthey in a research note on Monday, June 24th.

View Our Latest Analysis on JMAT

Johnson Matthey Trading Down 0.1 %

Shares of LON JMAT opened at GBX 1,468 ($19.39) on Monday. The company’s 50 day simple moving average is GBX 1,613.66 and its 200 day simple moving average is GBX 1,687.51. Johnson Matthey has a fifty-two week low of GBX 1,428.50 ($18.87) and a fifty-two week high of GBX 1,917.07 ($25.32). The firm has a market capitalization of £2.59 billion, a P/E ratio of 2,534.48, a P/E/G ratio of 49,242.50 and a beta of 0.95. The company has a debt-to-equity ratio of 63.15, a current ratio of 1.45 and a quick ratio of 0.76.

Insider Transactions at Johnson Matthey

In related news, insider Stephen Oxley acquired 21 shares of the stock in a transaction dated Wednesday, August 21st. The stock was bought at an average price of GBX 1,603 ($21.18) per share, with a total value of £336.63 ($444.69). Insiders purchased 66 shares of company stock valued at $107,901 over the last quarter. Corporate insiders own 0.61% of the company’s stock.

About Johnson Matthey

(Get Free Report

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Featured Stories

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.